Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Industry News

Baim Institute Names Dr. C. Michael Gibson As CEO

December 05, 2017

News Industry News

Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System

November 30, 2017

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

News Industry News

Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogic™ Heart Failure Diagnostic

September 19, 2017

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 27, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 26, 2017

News Daily News

Cardiologists Issue Call to Action to Improve CVD Care for Women

L.A. McKeown

July 11, 2017

News Daily News

US Lawmakers Urged India to Rethink Stent Price Cap Ahead of State Visit

Shelley Wood

June 27, 2017

News Industry News

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

May 25, 2017

News Conference News EuroPCR 2017

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

Shelley Wood

May 17, 2017

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

May 02, 2017

News Daily News

Boston Scientific Adds Two More TAVR Valves With Symetis Purchase

Michael O'Riordan

March 30, 2017

News Industry News

Siemens Healthineers and HeartFlow Collaborate to Provide Solution That Has Potential to Lower Cardiac Care Costs

March 21, 2017

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Caitlin E. Cox

February 06, 2017

Advertisement

Baim Institute Names Dr. C. Michael Gibson As CEO

Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogic™ Heart Failure Diagnostic

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Cardiologists Issue Call to Action to Improve CVD Care for Women

US Lawmakers Urged India to Rethink Stent Price Cap Ahead of State Visit

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

Boston Scientific Adds Two More TAVR Valves With Symetis Purchase

Siemens Healthineers and HeartFlow Collaborate to Provide Solution That Has Potential to Lower Cardiac Care Costs

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content